BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 30823359)

  • 1. Cholesterol and the Safety Factor for Neuromuscular Transmission.
    Krivoi II; Petrov AM
    Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30823359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar oxysterols may lead to opposite effects on synaptic transmission: Olesoxime versus 5α-cholestan-3-one at the frog neuromuscular junction.
    Kasimov MR; Zakyrjanova GF; Giniatullin AR; Zefirov AL; Petrov AM
    Biochim Biophys Acta; 2016 Jul; 1861(7):606-16. PubMed ID: 27102612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 5α-cholestan-3-one on the synaptic vesicle cycle at the mouse neuromuscular junction.
    Kasimov MR; Giniatullin AR; Zefirov AL; Petrov AM
    Biochim Biophys Acta; 2015 May; 1851(5):674-85. PubMed ID: 25725358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurophysiology of the neuromuscular junction: overview.
    Ruff RL
    Ann N Y Acad Sci; 2003 Sep; 998():1-10. PubMed ID: 14592857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Membrane cholesterol oxidation effects on synaptic vesicle cycle in frog (RANA ridibunda) motor nerve terminals].
    Petrov AM; Kasimov MR; Giniatullin AR; Zefirov AL
    Ross Fiziol Zh Im I M Sechenova; 2013 Feb; 99(2):245-60. PubMed ID: 23650738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A reminder of the structure and function of the skeletal neuromuscular junction].
    Molgó J; Colasante C; Benoit E; Poulain B
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S55-60. PubMed ID: 19576486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 24S-hydroxycholesterol suppresses neuromuscular transmission in SOD1(G93A) mice: A possible role of NO and lipid rafts.
    Mukhutdinova KA; Kasimov MR; Giniatullin AR; Zakyrjanova GF; Petrov AM
    Mol Cell Neurosci; 2018 Apr; 88():308-318. PubMed ID: 29550246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Major mechanisms involved in the synaptic transmission of the neuromuscular apparatus].
    Rigoard S; Wager M; Buffenoir K; Bauche S; Giot JP; Maixent JM; Rigoard P
    Neurochirurgie; 2009 Mar; 55 Suppl 1():S22-33. PubMed ID: 19230941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of P2Y12 receptors, NADPH oxidase, and lipid rafts in the action of extracellular ATP on synaptic transmission at the frog neuromuscular junction.
    Giniatullin A; Petrov A; Giniatullin R
    Neuroscience; 2015 Jan; 285():324-32. PubMed ID: 25463521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox-sensitive synchronizing action of adenosine on transmitter release at the neuromuscular junction.
    Tsentsevitsky A; Kovyazina I; Nikolsky E; Bukharaeva E; Giniatullin R
    Neuroscience; 2013 Sep; 248():699-707. PubMed ID: 23806718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressed Synaptic Transmission and Reduced Vesicle Release Sites in Huntington's Disease Neuromuscular Junctions.
    Khedraki A; Reed EJ; Romer SH; Wang Q; Romine W; Rich MM; Talmadge RJ; Voss AA
    J Neurosci; 2017 Aug; 37(34):8077-8091. PubMed ID: 28724748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cholesterol oxidase on neurotransmission and acetylcholine levels at the mice neuromuscular junctions.
    Zakirjanova GF; Giniatullin AR; Gafurova CR; Malomouzh AI; Fedorov NS; Khaziev AN; Tsentsevitsky AN; Petrov AM
    Arch Biochem Biophys; 2023 Nov; 749():109803. PubMed ID: 37955112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
    van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
    Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane cholesterol regulates different modes of synaptic vesicle release and retrieval at the frog neuromuscular junction.
    Rodrigues HA; Lima RF; Fonseca Mde C; Amaral EA; Martinelli PM; Naves LA; Gomez MV; Kushmerick C; Prado MA; Guatimosim C
    Eur J Neurosci; 2013 Oct; 38(7):2978-87. PubMed ID: 23841903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol in myasthenia gravis.
    Paz ML; Barrantes FJ
    Arch Biochem Biophys; 2021 Apr; 701():108788. PubMed ID: 33548213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenoceptors Modulate Cholinergic Synaptic Transmission at the Neuromuscular Junction.
    Bukharaeva E; Khuzakhmetova V; Dmitrieva S; Tsentsevitsky A
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant morphology and residual transmitter release at the Munc13-deficient mouse neuromuscular synapse.
    Varoqueaux F; Sons MS; Plomp JJ; Brose N
    Mol Cell Biol; 2005 Jul; 25(14):5973-84. PubMed ID: 15988013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homeostatic Plasticity of the Mammalian Neuromuscular Junction.
    Engisch KL; Wang X; Rich MM
    Adv Neurobiol; 2022; 28():111-130. PubMed ID: 36066823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current concepts in neuromuscular transmission.
    Fagerlund MJ; Eriksson LI
    Br J Anaesth; 2009 Jul; 103(1):108-14. PubMed ID: 19546202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic principles of neuromuscular transmission.
    Martyn JA; Fagerlund MJ; Eriksson LI
    Anaesthesia; 2009 Mar; 64 Suppl 1():1-9. PubMed ID: 19222426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.